$14.69
0.987.15%
At close: Jun 9, 5:00 PM EST
$15.00
0.312.11%
After Hours: 5:17 PM EST
Amneal Pharmaceuticals Inc Earnings Estimates
AMRXNASDAQ
Amneal Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:AMRX
Amneal Pharmaceuticals (AMRX) is scheduled to report Q2 earnings on August 4, 2026. Analysts estimate EPS of $0.23 and quarterly revenue of $763.47M.
In the most recent quarter (Q1), Amneal Pharmaceuticals reported EPS of $0.27, beating estimates of $0.17 by 0.59%. Revenue came in at $722.52M, exceeding the estimate of $715.38M by 0.01%.
Amneal Pharmaceuticals has beaten EPS estimates in 5 consecutive quarters.
Over the last 4 quarters, Amneal Pharmaceuticals has averaged an EPS surprise of 0.38% and a revenue surprise of 0.01%.
Earnings Date
Aug 4
EPS Estimate
$0.230
Quarterly Revenue Estimate
$763.47M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$3.05B
Amneal Pharmaceuticals Earnings History
Analyze the earnings history of Amneal Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Amneal Pharmaceuticals (AMRX) Earnings Per Share
The chart below shows Amneal Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Amneal Pharmaceuticals (AMRX) Revenue
The chart below shows Amneal Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Amneal Pharmaceuticals (NASDAQ:AMRX) reporting earnings?
Amneal Pharmaceuticals (AMRX) is scheduled to report earnings on August 4, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Amneal Pharmaceuticals (NASDAQ:AMRX)?
The Actual EPS was $0.27, which beat the estimate of $0.17.
What were Amneal Pharmaceuticals’s (NASDAQ:AMRX) revenues?
The Actual Revenue was $722.52M, which beat the estimate of $715.38M.
